The European Medicines Agency (EMA) approved on Friday July 23 the use of the anti-Covid Moderna vaccine for 12-17 year olds, which becomes the second vaccine to be authorized for adolescents in the 27 countries of the Union European.
“
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended to grant an extension of indication to the COVID-19 vaccine Spikevax (formerly Covid-19 Vaccine Moderna) to include its use in children aged 12 to 17 years,
”said the European regulator in a press release.